India’s defence manufacturing is on track to surpass ₹1.6 lakh crore in value this year: Defence Minister Rajnath Singh
Our defence exports should reach ₹30,000 crore this year and ₹50,000 crore by the year 2029: Defence Minister Rajnath Singh
The day is not far when India will not only emerge as a developed country, but our military power will also emerge as the number one in the world: Defence Minister Rajnath Singh
Indian drug firms are eyeing a larger share of the $145 billion US oncology market, which is growing at an 11% CAGR
In the past few months, several Indian drug firms have received US FDA approvals for oncology generics
Indian firms have been focusing on complex generics for some time now, which insulates them partially from pricing pressures in the generics space in the US
Parents of children with spinal muscular atrophy welcomed the announcement by Natco, that it would be providing the generic version of the SMA drug risdiplam at a fraction of the price
From roughly Rs 72 lakh per year to treat an adult patient with SMA, the cost could fall to about Rs 5 lakh per year with generic production
Natco revealed in a “legal update regarding Risdiplam launch in India” that the “company has decided to price the product (Risdiplam) at Rs 15,900” per 60 mg bottle
India’s economic progress is deeply interwoven with the success of its MSMEs
Today, the Mudra loan has become a vital financial lifeline for the unorganised and underserved segments
The MSME sector not only serves as the backbone of our economy but also plays a pivotal role in employment generation and fostering grassroots innovation
Minister for road transport, Nitin Gadkari announced plans to invest Rs 10 lakh crore in national highway projects over the next two years, focusing on the Northeast and border areas
India's road network is the second-largest in the world, and the NH network has grown by 60% in the last decade
NHAI’s debt reduced from ₹3.5 lakh crore to ₹2.76 lakh crore, highlighting better financial management